Cencora gets a buy rating, agreeing with today's consensus from Wall St. The sector and macro environment point to continued demand for the healthcare supplies and niche specialty drugs Cencora ...

In its first-quarter 2025 investor letter, TimesSquare Capital U.S. Focus Growth Strategy highlighted stocks such as Cencora, Inc. (NYSE:COR). Cencora, Inc. (NYSE:COR) is a pharmaceutical products ...

The most recent earnings report from Cencora, Inc. (NYSE:COR) was disappointing for shareholders. While the headline numbers were soft, we believe that investors might be missing some encouraging ...

Conshohocken, Pennsylvania-based Cencora, Inc. (COR) is a pharmaceutical sourcing and distribution company. With a market cap of approximately $54 billion, Cencora operates through the U.S ...

Looking at the universe of stocks we cover at Dividend Channel, on 5/16/25, Eli Lilly (Symbol: LLY), Cencora Inc (Symbol: COR), and Royalty Pharma plc (Symbol: RPRX) will all trade ex-dividend for ...

LONDON - Cencora, Inc., a company whose securities are listed on the New York Stock Exchange, has concluded a post-stabilisation period without any stabilisation activities being conducted ...

In this article, we are going to take a look at where Cramer noted that while Cencora, Inc. (NYSE:COR) stands against other stocks that Jim Cramer discussed recently. On Wednesday’s episode of ...

NEW YORK - J.P. Morgan Securities plc has announced that it may take actions to stabilize the market price of Cencora, Inc.’s newly offered securities, which include EUR 3-year and 7-year fixed ...

We recently published a list of 8 Stocks on Jim Cramer’s Radar Recently. In this article, we are going to take a look at where Cramer noted that while Cencora, Inc. (NYSE:COR) stands against other ...